Core B: Integrated Microscopy Core

Information

  • Research Project
  • 10216277
  • ApplicationId
    10216277
  • Core Project Number
    P20GM121310
  • Full Project Number
    5P20GM121310-05
  • Serial Number
    121310
  • FOA Number
    PAR-14-035
  • Sub Project Id
    6520
  • Project Start Date
    9/1/2017 - 7 years ago
  • Project End Date
    7/31/2022 - 2 years ago
  • Program Officer Name
  • Budget Start Date
    8/1/2021 - 3 years ago
  • Budget End Date
    7/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
  • Award Notice Date
    7/19/2021 - 3 years ago
Organizations

Core B: Integrated Microscopy Core

Abstract The overall goal of the research core is to enhance the ability of researchers to elucidate how sensory systems work and how disease/pathological states occur. To do so, we propose to strengthen and expand the capabilities of the existing Microscopy Core by creating an Integrated Microscopy Core (IMcore). The IMcore is built on the three main service components.1) Microscopy Core, 2) the Antibody Unit (AU), and 3) Molecular Analysis Unit (MAU). All components will be integrated physically and thematically into the existing Microscopy Core. Dr. Zhaojie Zhang, the current state-funded director, who has provided the leadership to establish the Microscopy Core as a critical institutional facility, will continue in this role as Director of the IMcore. A multi- disciplinary team of scientists and technicians will manage the day-to-day operation of the three components. Two specific aims are proposed. Aim 1. To update and expand the existing microscopy core to create IMcore, and to provide a platform to promote collaborations and training necessary to meet the imaging needs of the investigators. A multi-photon microscope with high speed and high resolution is needed to map out large sensory network in three dimensions in vivo and in vitro. Aim 2. To expand the service capabilities of the IMcore by providing antibody screening and development and molecular analytic capabilities. We will expand the existing core to include antibody development and validation. The validation of antibodies uses a variety of molecular techniques including western blotting, immunoprecipitation, knock-out animals, and PCR to relate message to proteins. Services and instruments enabling the application of the new state-of-the-art high- throughput ?molecular imaging? (e.g., ChIP-seq, RNA-seq) of the nervous system utilizing, in part, outside fee- for-service next generation facilities will be developed. Successful expansion of the current Microscopy Core will integrate new capacities that will: 1) meet future technical challenges and enable innovative research by SBC investigators, 2) foster new and stronger collaborations among SBC investigators and in doing so, 3) pave the way for SBC investigators to undertake collaborative and groundbreaking approaches to understand how sensory systems work and how disease/pathological states occur.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    P20
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    318498
  • Indirect Cost Amount
    141732
  • Total Cost
  • Sub Project Total Cost
    460230
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIGMS:460230\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF WYOMING
  • Organization Department
  • Organization DUNS
    069690956
  • Organization City
    LARAMIE
  • Organization State
    WY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    820712000
  • Organization District
    UNITED STATES